X0508 4 2024-11-27 0001682852 Moderna, Inc. MRNA 0001736359 Mock James M 325 BINNEY STREET CAMBRIDGE MA 02142 1 Chief Financial Officer 1 Common Stock 2024-11-27 4 M 0 1326 A 10831 D Common Stock 2024-11-27 4 M 0 329 A 11160 D Common Stock 2024-11-27 4 M 0 1326 A 12486 D Common Stock 2024-11-29 4 S 0 1420 42.7891 D 11066 D Performance Stock Units 2024-11-27 4 M 0 1326 0 D Common Stock 1326 1326 D Restricted Stock Units 2024-11-27 4 M 0 329 0 D Common Stock 329 2959 D Restricted Stock Units 2024-11-27 4 M 0 1326 0 D Common Stock 1326 1326 D Performance stock units convert into common stock on a one-for-one basis. Restricted stock units convert into common stock on a one-for-one basis. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs and PSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent a discretionary trade by the Reporting Person. 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025. 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. /s/ James Dillon, As Attorney-in-Fact 2024-12-02